![Kate Plumridge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Kate Plumridge
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kate Plumridge tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The University of New Mexico | College/University | Undergraduate Degree | |
Baylor College of Medicine | College/University | Doctorate Degree | |
Hereditary Disease Foundation | Corporate Officer/Principal | ||
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Belgio | 2 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
C. Bennett | 8 |
- Borsa valori
- Insiders
- Kate Plumridge
- Connessioni Società